Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
9.37
-0.21 (-2.19%)
At close: Sep 12, 2025, 4:00 PM EDT
9.40
+0.03 (0.32%)
After-hours: Sep 12, 2025, 7:56 PM EDT
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $804.83 million as of September 12, 2025. Its market cap has increased by 49.24% in one year.
Market Cap
804.83M
Enterprise Value
703.66M
1-Year Change
49.24%
Ranking
Category
Stock Price
$9.37
Market Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has increased from $284.60M to $804.83M, an increase of 182.79%. That is a compound annual growth rate of 11.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 822.90M | -9.66% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
| Oct 28, 2015 | 284.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.94B |
| Johnson & Johnson | 421.46B |
| AbbVie | 371.54B |
| UnitedHealth Group | 311.68B |
| AstraZeneca | 251.31B |
| Novartis AG | 248.23B |
| Novo Nordisk | 236.38B |
| Abbott Laboratories | 223.02B |